High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression

R Sgarra, S Pegoraro, G Ros, C Penzo… - … et Biophysica Acta (BBA …, 2018 - Elsevier
Cancer heterogeneity is one of the factors that constitute an obstacle towards an efficient
targeting of this multifaceted disease. Molecular information can help in classifying cancer …

Roles of tristetraprolin in tumorigenesis

JM Park, TH Lee, TH Kang - International journal of molecular sciences, 2018 - mdpi.com
Genetic loss or mutations in tumor suppressor genes promote tumorigenesis. The
prospective tumor suppressor tristetraprolin (TTP) has been shown to negatively regulate …

Role of exosomal competing endogenous RNA in patients with hepatocellular carcinoma

A Abd El Gwad, M Matboli, A El‐Tawdi… - Journal of cellular …, 2018 - Wiley Online Library
Recent research has tried to use exosomal RNAs (coding and noncoding) as potential
diagnostic markers for hepatocellular carcinoma (HCC). Initially, by using bioinformatics, we …

The role of RNA-binding protein tristetraprolin in cancer and immunity

J Guo, H Qu, Y Chen, J Xia - Medical oncology, 2017 - Springer
RNA-binding protein tristetraprolin (TTP) plays a fundamental role in various physiological
and pathological processes including differentiation, reprogramming, metabolism …

[Retracted] ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress

D Yuan, Y Fang, W Chen, K Jiang… - Oxidative Medicine …, 2022 - Wiley Online Library
Background. The expression of ZFP36 in previous study was reduced in prostate cancer
(PCa) tissues as compared to benign prostate tissues, indicating the potential of ZFP36 as …

Long non-coding RNA EGOT promotes the malignant phenotypes of hepatocellular carcinoma cells and increases the expression of HMGA2 via down-regulating miR …

S Wu, H Ai, K Zhang, H Yun, F Xie - OncoTargets and therapy, 2019 - Taylor & Francis
Background Chronic hepatitis C virus (HCV) infection is an important risk factor for
hepatocellular carcinoma (HCC). EGOT is a long non-coding RNA (lncRNA) induced after …

Tumor-linked macrophages promote HCC development by mediating the CCAT1/Let-7b/HMGA2 signaling pathway

L Deng, S Huang, B Chen, Y Tang, F Huang… - OncoTargets and …, 2020 - Taylor & Francis
Background The role of high mobility group A2 (HMGA2) in the progression of
hepatocellular carcinoma (HCC) is yet to be investigated, though tumor-associated …

[PDF][PDF] 高迁移率蛋白A2 在原发性肝癌组织中的表达及临床意义

步楠, 李姗姗, 潘克明, 苏越, 赵春红 - 中国中西医结合消化杂志, 2022 - zxyxh.whuhzzs.com
目的: 研究高迁移率蛋白A2 (HMGA2) 在原发性肝细胞癌(HCC) 组织中的表达及临床意义. 方法:
选择2017 年1 月—2019 年12 月在佳木斯市中医院接受手术切除的原发性HCC …

Expression and clinical significance of HMGA2 in hepatocellular carcinoma

BU Nan, LI Shanshan, PAN Keming… - Chin J Integr Tradit …, 2022 - zxyxhen.whuhzzs.com
Expression and clinical significance of HMGA2 in hepatocellular carcinoma Homepage
Journals 1.{{journal.titleEn}} {{journal.titleEn}} {{journal.titleEn}} {{journal.titleEn}} {{subColumn.name}} …